![PDF) Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: Outcome assessment applying a predictive scoring system PDF) Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: Outcome assessment applying a predictive scoring system](https://i1.rgstatic.net/publication/305483669_Y90_Radioembolization_in_chemo-refractory_metastastic_liver_dominant_colorectal_cancer_patients_Outcome_assessment_applying_a_predictive_scoring_system/links/5fc21285458515b7977cb31d/largepreview.png)
PDF) Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: Outcome assessment applying a predictive scoring system
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
![Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2549-x/MediaObjects/12885_2016_2549_Fig2_HTML.gif)
Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text
![PDF) Superficial skin cancer therapy with Y-90 microspheres: A feasibility study on patch preparation PDF) Superficial skin cancer therapy with Y-90 microspheres: A feasibility study on patch preparation](https://i1.rgstatic.net/publication/334646218_Superficial_skin_cancer_therapy_with_Y-90_microspheres_A_feasibility_study_on_patch_preparation/links/5d381247a6fdcc370a5a6c97/largepreview.png)
PDF) Superficial skin cancer therapy with Y-90 microspheres: A feasibility study on patch preparation
Transcatheter arterial embolization of acute bleeding as 24/7 service: predictors of outcome and mortality
![Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma - Journal of Hepatology Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/07eeb6bb-5dae-4958-80ad-9dae7ac9bbb0/ga1.jpg)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma - Journal of Hepatology
Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma
![Dennis Kupitz's research works | Otto-von-Guericke-Universität Magdeburg, Magdeburg (OvGU) and other places Dennis Kupitz's research works | Otto-von-Guericke-Universität Magdeburg, Magdeburg (OvGU) and other places](https://www.researchgate.net/publication/349393412/figure/fig1/AS:992440710352919@1613627712559/a-c-Pre-OP-SPECT-CT-images-from-a-patient-f-46year-SPECT-CT-5months_Q320.jpg)
Dennis Kupitz's research works | Otto-von-Guericke-Universität Magdeburg, Magdeburg (OvGU) and other places
![Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2549-x/MediaObjects/12885_2016_2549_Fig3_HTML.gif)
Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text
![Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers. - Abstract - Europe PMC Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4136939/bin/medscimonit-20-1353-g001.jpg)
Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers. - Abstract - Europe PMC
![PDF) Safety of Repeated Radioembolizations in Patients with Advanced Primary and Secondary Liver Tumors and Progressive Disease After First Selective Internal Radiotherapy PDF) Safety of Repeated Radioembolizations in Patients with Advanced Primary and Secondary Liver Tumors and Progressive Disease After First Selective Internal Radiotherapy](https://i1.rgstatic.net/publication/260154604_Safety_of_Repeated_Radioembolizations_in_Patients_with_Advanced_Primary_and_Secondary_Liver_Tumors_and_Progressive_Disease_After_First_Selective_Internal_Radiotherapy/links/564c980508ae3374e5e051ed/largepreview.png)
PDF) Safety of Repeated Radioembolizations in Patients with Advanced Primary and Secondary Liver Tumors and Progressive Disease After First Selective Internal Radiotherapy
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
![Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2549-x/MediaObjects/12885_2016_2549_Fig1_HTML.gif)
Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text
![Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine](https://www.researchgate.net/publication/351042179/figure/tbl1/AS:1022432219504640@1620778245821/Toxicity-analysis_Q320.jpg)
Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
![International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres | SpringerLink International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres | SpringerLink](https://media.springernature.com/w200/springer-static/cover/journal/259.jpg)